Sebastian Szklener

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Challenges for Service Robots—Requirements of Elderly Adults with Cognitive Impairments

Agnieszka Korchut, Sebastian Szklener, Carla Abdelnour et al. · Frontiers in Neurology · 2017 · 82 citations · Full text

Assessment of Perceived Attractiveness, Usability, and Societal Impact of a Multimodal Robotic Assistant for Aging Patients With Memory Impairments

Justyna Gerłowska, Urszula Skrobas, Katarzyna Grabowska-Aleksandrowicz et al. · Frontiers in Neurology · 2018 · 55 citations · Full text

Predictive model for patients with poor-grade subarachnoid haemorrhage in 30-day observation: a 9-year cohort study

Sebastian Szklener, Anna Melges, Agnieszka Korchut et al. · BMJ Open · 2015 · 23 citations · Full text

Systemic inflammatory response syndrome in the course of status epilepticus: 7-year, two-center observational study

Sebastian Szklener, Agnieszka Korchut, Magdalena Godek et al. · Epilepsy Research · 2017 · 22 citations

Inflammation, Clinical Disorders, Psychoneuroimmunology +9